Frontline medical staff in Manchester have developed an innovative PPE respirator that could provide a breakthrough in the fight against coronavirus (COVID-19).
Staff in the Intensive Care Unit at Wythenshawe Hospital, which is part of Manchester University NHS Foundation Trust (MFT), have developed Bubble PAPR – a Powered Air-Purifying Respirator (PAPR) – to keep healthcare workers safe during the coronavirus (COVID-19) pandemic.
According to a statement on the Manchester University NHS Foundation Trust website, the “simple and low-cost device” consists of a reusable collar that sits around the neck and a single-use plastic hood that can be easily recycled.
The collar contains a fan to draw in air through a virus filter and deliver a cooling airflow around the face.
Bubble PAPR has been designed to be compatible with stringent infection control practices and be comfortable to wear for the duration of a shift in the ICU, or other high-risk areas. The wearer’s face is clearly visible, which will improve critical communication between staff and vastly improving the patient experience.
ADVERTISEMENT
Dr Brendan McGrath – Intensive Care Consultant at Wythenshawe Hospital – has been the clinical lead through the development and testing process. He said: “We have tested Bubble PAPR and we know it performs its primary function which is to protect staff against inhalation of airborne viruses.
“We have also now tested it in the simulated clinical environment.
ADVERTISEMENT
“The reaction from staff has been overwhelmingly positive: they saw something that was not restrictive on their face, that allowed them to communicate with their colleagues, that was pleasant to wear and will allow them to interact with their patients.”
Intensive care staff at @WythenshaweHosp have developed @BubblePapr – an innovative PPE respirator that could be a massive breakthrough in keeping NHS staff safe while delivering life-saving care during #COVID19.
The Bubble PAPR is part of an ongoing collaboration between MFT, Designing Science and The University of Manchester.
The collaboration will identify unmet clinical needs and work collaboratively to develop new solutions.
ADVERTISEMENT
A patent has been filed and the development team are now working with manufacturing partners to produce Bubble PAPR in large volumes and signing up distribution partners.
Patrick Hall – MD of Designing Science – added:
“Most current PAPRs are re-purposed industrial devices, not designed for clinical use and expensive. We have taken a user centred design approach to engineer and develop the Bubble PAPR to be as simple as possible while meeting key functional and ergonomic requirements. This means it can be easily and cheaply manufactured in large volumes so it can be made available right across the healthcare system, wherever clinical and support staff are interacting with patients who have confirmed or suspected COVID-19 or other serious infections.”
Dr Glen Cooper – Program Director for Mechanical Engineering Design in the School of Engineering at The University of Manchester – said: “The Bubble PAPR is both ergonomically and mechanically the right product to meet the need to protect NHS staff during the COVID crisis and beyond.”
The aim is to have Bubble PAPR widely available for front line staff before the end of 2020.
You can find more information via the MFT website here.
ADVERTISEMENT
___
For the latest information, guidance and support during the coronavirus (COVID-19) pandemic in the UK, please do refer to official sources at gov.uk/coronavirus.
#HandsFaceSpace
News
Arrest made after 14-year-old boy found in critical condition on Market Street
Daisy Jackson
An arrest has been made after a teenage boy was found unresponsive on Market Street in Manchester city centre.
Detectives believe that the boy, 14, was approached by seven males who stole a designer jacket from him.
Following the altercation, he went into cardiac arrest and was rushed to hospital in a critical condition.
Thankfully, the teenager is continuing to recover well.
Detectives from Manchester City Centre Criminal Investigation Department confirmed that an 18-year-old male was arrested yesterday, Thursday 20 February.
He has been arrested on suspicion of robbery and remains in police custody.
Detective Inspector Mark Astbury of GMP’s City Centre Criminal Investigation Department, said: “We hope the victim can continue his recovery following what must have been a terrifying ordeal for him.
“Officers are fully investigating all aspects of this shocking incident that has left a man with serious injuries in hospital.
“Our work doesn’t stop here, we are continuing to investigate this incident and information from the public plays an incredibly important role in our investigations and I ask that the community keep talking to us and keep sharing their concerns with us so our teams can act.”
If you have any information, contact GMP 101 or 0161 856 4305 quoting log 2854 of 16/2/25.
Comedy is being prescribed instead of antidepressants as part of UK trials
Emily Sergeant
Trials are currently underway to see if comedy could be an alternative to antidepressants as a way to reduce NHS costs.
UK tech company Craic Health has secured important funding for its ‘comedy on prescription’ project that’s aimed at helping the Government work with the comedy industry, communities, and organisations on comedy-based social prescriptions in the hope that they can solve financial struggles within the NHS.
The groundbreaking scheme uses stand-up shows and workshops to help people who are isolated, lonely, and vulnerable.
Craic believes comedy is an ‘untapped opportunity’ to improve health and wellbeing, and has a goal to make comedy easier to access, so that it can help communities experience its mental health and social benefits.
To achieve this, the company has started trialling Comedy-on-Prescription experiences in the UK – starting in London, with the potential for expansion – which includes things like curated comedy panel game show events and workshops, and general stand-up comedy shows at some of the capital’s world-famous venues.
Comedy is being prescribed instead of antidepressants as part of UK trials / Credit: Wikimedia Commons
“Mental health issues like loneliness, isolation, and stress are more common than ever,” the company explains.
“So much so that it’s projected that by 2030, mental health problems, particularly depression, will be the leading cause of mortality and morbidity globally, [but] in this challenging world, comedy stands out as a universal language that breaks barriers.
“Research shows that comedy and laughter have powerful effects – they bring people together, create positive connections, and make life more enjoyable.”
Craic Health says that social prescribing, of which Comedy-on-Prescription is a part of, is all about inclusivity, which makes it making it suitable for people of all ages, backgrounds, and abilities.
Its focus is on personalised support, tailored to individual needs and preferences.